TRIMACONTIN 35 (Trimetazidine (35mg))

Trimacontin 35 Tablet is indicated for the management of angina pectoris, a condition characterized by chest discomfort arising from diminished blood flow to the heart muscle. This medication aids in optimizing the heart’s efficiency by enhancing its oxygen utilization. It offers protective effects on cardiac cells during episodes of decreased oxygen availability, thereby potentially decreasing both the frequency and intensity of angina episodes. It is essential to adhere strictly to your healthcare provider’s instructions regarding the dosage, which is typically administered twice daily with meals. To achieve the best therapeutic outcomes, it is advisable to incorporate heart-healthy lifestyle changes, which may include engaging in regular physical exercise, ceasing tobacco use, and maintaining a balanced diet that is low in fats. It is important not to omit doses or discontinue the medication without consulting your healthcare professional, as doing so may lead to a resurgence of symptoms. Trimacontin 35 Tablet is not designed for the immediate relief of acute chest pain. Patients with Parkinson’s disease, certain movement disorders, or severe renal impairments should avoid this medication. If you experience dizziness or instability while on this treatment, it is recommended to refrain from driving or operating machinery. Always inform your healthcare provider of any other medications you are taking or any medical conditions you have.